IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,170,366 | +1454.1% | 136,031 | +1194.1% | 0.07% | +1100.0% |
| Q4 2022 | $397,038 | +12.5% | 10,512 | +10.3% | 0.01% | -14.3% |
| Q2 2022 | $353,000 | -15.6% | 9,531 | -30.6% | 0.01% | +133.3% |
| Q4 2021 | $418,000 | -97.1% | 13,740 | -95.7% | 0.00% | -98.1% |
| Q1 2021 | $14,366,000 | +6907.8% | 319,539 | +7281.4% | 0.16% | +3950.0% |
| Q3 2020 | $205,000 | -71.1% | 4,329 | -64.0% | 0.00% | -82.6% |
| Q2 2020 | $710,000 | -19.2% | 12,041 | -26.0% | 0.02% | -63.5% |
| Q4 2018 | $879,000 | +111.8% | 16,262 | +72.6% | 0.06% | +103.2% |
| Q1 2018 | $415,000 | +64.7% | 9,421 | +89.6% | 0.03% | +55.0% |
| Q3 2017 | $252,000 | -66.0% | 4,970 | -65.9% | 0.02% | -72.2% |
| Q2 2017 | $742,000 | +237.3% | 14,580 | +54.7% | 0.07% | +157.1% |
| Q2 2016 | $220,000 | -73.0% | 9,427 | -28.5% | 0.03% | -81.9% |
| Q4 2015 | $816,000 | – | 13,176 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |